Host: Keith C. Ferdinand, MD, FACC, FAHA , FASPC, FNLA, FPCNA

A concerning number of patients with atherosclerotic cardiovascular disease (ASCVD) reached suboptimal LDL-C levels between 2021 and 2022. Even with new strategies that can help lower LDL-C, an analysis of over 3 million ASCVD patients in the Family Heart Database shows that these treatments are not being properly utilized. Join Dr. Keith C. Ferdinand as he delves into an analysis of management trends among these patients, which he presented at the 2024 Family Heart Foundation Global Summit. Dr. Ferdinand is a Professor of Medicine and the Gerald S. Berenson Endowed Chair in Preventative Cardiology at the Tulane University School of Medicine in New Orleans, Louisiana.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Emily Carroll, JD, MSW

The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.

Host: Andrew Wilner, MD, FACP, FAAN

Guest: William W. Li, MD

As the number of new COVID-19 infections continues to decrease and the United States begins to open back up, it’s important to note that there are patients who have survived COVID-19 but are still suffering. The newly coined term “COVID long-haulers” refers to those patients who continue to have symptoms even after the acute infection is resolved. Joining Dr. Andrew Wilner to share what we know so far about COVID long-haulers and how we can help them is vascular biologist Dr. William Li.

Host: Peter Buch, MD, FACG, AGAF, FACP

Guest: Adam Olsen, MS, PA-C

Millions of patients are treated with anticoagulants, and many more are treated with antiplatelet therapy. But when those therapies overlap with GI bleeding, what do you need to know so that your patients don’t experience any problematic health outcomes? Dr. Peter Buch is discussing this topic with physician assistant Mr. Adam Olsen, who’s the Department Chair and Program Director for the Master of Physician Assistant Studies Program at Sacred Heart University in Stamford, Connecticut.

Host: Jerome Lisk, MD, MBA, M.S., FAAN

Guest: Ilan Wittstein, MD

How do you mend a broken heart? Dr. Ilan Wittstein, the Director of the Advanced Heart Failure Fellowship and Assistant Professor of Medicine at Johns Hopkins School of Medicine, joins Dr. Jerome Lisk to discuss broken heart syndrome and some of its challenges.

Host: Jerome Lisk, MD, MBA, M.S., FAAN

Guest: Ilan Wittstein, MD

With no standard criteria available, how do we detect broken heart syndrome in our patients? Dr. Ilan Wittstein, the Director of the Advanced Heart Failure Fellowship and Assistant Professor of Medicine at Johns Hopkins School of Medicine, shares what we should be looking for.

Host: Matthew J. Sorrentino, MD, FACC, FASH

Guest: Salim S. Virani, MD, PhD, FACC, FAHA, FASPC

What is the leading cause of death worldwide? Dr. Matthew Sorrentino sits down with Dr. Salim Virani, who's a professor of medicine at Baylor College of Medicine in Houston, Texas, and the Cardiovascular Disease Fellowship director at Baylor, to discuss how the COVID-19 pandemic has impacted cardiovascular disease globally.

Host: Matthew J. Sorrentino, MD, FACC, FASH

Guest: C. Michael Gibson, MD, FSCAI

Following a major cardiovascular event, what interventional strategies should we be considering? Dr. Matthew Sorrentino joins Dr. Michael Gibson, a professor of medicine and cardiology at the Beth Israel Deaconess Medical Center at Harvard Medical School in Boston, Massachusetts to discuss antiplatelet and anticoagulation strategies for patients with cardiovascular disease.

Host: Matthew J. Sorrentino, MD, FACC, FASH

Guest: Eliot Brinton

What do we need to know about the impact of triglyceride levels? Dr. Elliot Brinton, President at the Utah Lipid Center in Salt Lake City briefly dives into the impact that triglycerides have on our endothelial cells and LDL cholesterol.

Host: Matthew J. Sorrentino, MD, FACC, FASH

Guest: Alan S. Brown, MD, FACC, FAHA, FNLA

With an explosion in new medications to treat diabetes, Heart Matters hosts Dr. Matthew Sorrentino and Dr. Alan Brown sit down to discuss the cardiovascular risk benefits of these new diabetes treatments and how cardiologists can improve patient care.